Unichem Laboratories vs Peers
- Market cap
- ₹3,668 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹375.08 – ₹703.28
Unichem Laboratories ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Unichem Laboratories. Its P/E of 22.5 compares with a peer median of 22.5.
Unichem Laboratories vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Unichem Laboratories | 520.95 | -4.62% | 3,668 | 22.5 | 2.85 | 14.5% | +18.5% |
| Unichem Laboratories | 520.95 | -4.62% | 3,668 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Unichem Laboratories peer comparison — frequently asked questions
Who are Unichem Laboratories' competitors?
Unichem Laboratories' listed peers in Drug Manufacturers - Specialty & Generic include Unichem Laboratories, ranked here by market capitalisation.
How does Unichem Laboratories' P/E compare with its peers?
Unichem Laboratories trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Unichem Laboratories' peers?
By market capitalisation, the largest company in the group is Unichem Laboratories at ₹3,668 crore, against ₹3,668 crore for Unichem Laboratories.
Same Data For Peers
Trade Unichem Laboratories With ATS
Track UNICHEMLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.